Cerebrovascular events have emerged as a central feature of the clinical syndrome associated with
Sars-CoV-2 infection. This increase in
infection-related
strokes is marked by atypical presentations including
stroke in younger patients and a high rate of hemorrhagic transformation after
ischemia. A variety of pathogenic mechanisms may underlie this connection. Efforts to identify synergism in the pathophysiology underlying
stroke and
Sars-CoV-2 infection can inform the understanding of both conditions in novel ways. In this review, the molecular cascades connected to
Sars-CoV-2 infection are placed in the context of the cerebral vasculature and in relationship to pathways known to be associated with
stroke.
Cytokine-mediated promotion of systemic
hypercoagulability is suggested while direct
Sars-CoV-2 infection of cerebral endothelial cells may also contribute. Endotheliopathy resulting from direct
Sars-CoV-2 infection of the cerebral vasculature can modulate ACE2/AT1R/MasR signaling pathways, trigger direct viral activation of the
complement cascade, and activate feed-forward
cytokine cascades that impact the blood-brain barrier. All of these pathways are already implicated as independent mechanisms driving
stroke and cerebrovascular injury irrespective of Sars-CoV-2. Recognizing the overlap of molecular pathways triggered by
Sars-CoV-2 infection with those implicated in the pathogenesis of
stroke provides an opportunity to identify future
therapeutics targeting both Sars-CoV-2 and
stroke thereby reducing the impact of the global pandemic.